Periodic monitoring for fat-soluble vitamin deficiency is recommended.

Hearing screening is recommended at five-year intervals in individuals with no symptomatic evidence of hearing deficits.

Monitoring for hepatobiliary malignancy has not been shown to be necessary in ATP8B1 deficiency.
